109 related articles for article (PubMed ID: 25979818)
1. Pioneer translation products as an alternative source for MHC-I antigenic peptides.
Apcher S; Daskalogianni C; Fåhraeus R
Mol Immunol; 2015 Dec; 68(2 Pt A):68-71. PubMed ID: 25979818
[TBL] [Abstract][Full Text] [Related]
2. Proteolytic enzymes involved in MHC class I antigen processing: A guerrilla army that partners with the proteasome.
Lázaro S; Gamarra D; Del Val M
Mol Immunol; 2015 Dec; 68(2 Pt A):72-6. PubMed ID: 26006050
[TBL] [Abstract][Full Text] [Related]
3. Nuclear processing of nascent transcripts determines synthesis of full-length proteins and antigenic peptides.
Martins RP; Malbert-Colas L; Lista MJ; Daskalogianni C; Apcher S; Pla M; Findakly S; Blondel M; Fåhraeus R
Nucleic Acids Res; 2019 Apr; 47(6):3086-3100. PubMed ID: 30624716
[TBL] [Abstract][Full Text] [Related]
4. Translation of pre-spliced RNAs in the nuclear compartment generates peptides for the MHC class I pathway.
Apcher S; Millot G; Daskalogianni C; Scherl A; Manoury B; Fåhraeus R
Proc Natl Acad Sci U S A; 2013 Oct; 110(44):17951-6. PubMed ID: 24082107
[TBL] [Abstract][Full Text] [Related]
5. Production of spliced peptides by the proteasome.
Vigneron N; Stroobant V; Ferrari V; Abi Habib J; Van den Eynde BJ
Mol Immunol; 2019 Sep; 113():93-102. PubMed ID: 29650230
[TBL] [Abstract][Full Text] [Related]
6. Invariant chain as a vehicle to load antigenic peptides on human MHC class I for cytotoxic T-cell activation.
Wälchli S; Kumari S; Fallang LE; Sand KM; Yang W; Landsverk OJ; Bakke O; Olweus J; Gregers TF
Eur J Immunol; 2014 Mar; 44(3):774-84. PubMed ID: 24293164
[TBL] [Abstract][Full Text] [Related]
7. mRNA translation from an antigen presentation perspective: A tribute to the works of Nilabh Shastri.
Apcher S; Tovar-Fernadez M; Ducellier S; Thermou A; Nascimento M; Sroka E; Fahraeus R
Mol Immunol; 2022 Jan; 141():305-308. PubMed ID: 34920325
[TBL] [Abstract][Full Text] [Related]
8. The role of mRNA translation in direct MHC class I antigen presentation.
Apcher S; Manoury B; Fåhraeus R
Curr Opin Immunol; 2012 Feb; 24(1):71-6. PubMed ID: 22341517
[TBL] [Abstract][Full Text] [Related]
9. Major source of antigenic peptides for the MHC class I pathway is produced during the pioneer round of mRNA translation.
Apcher S; Daskalogianni C; Lejeune F; Manoury B; Imhoos G; Heslop L; Fåhraeus R
Proc Natl Acad Sci U S A; 2011 Jul; 108(28):11572-7. PubMed ID: 21709220
[TBL] [Abstract][Full Text] [Related]
10. Standard and immunoproteasomes show similar peptide degradation specificities.
Zanker D; Chen W
Eur J Immunol; 2014 Dec; 44(12):3500-3. PubMed ID: 25399798
[TBL] [Abstract][Full Text] [Related]
11. Major histocompatibility class I antigenic peptides derived from translation of pre-mRNAs generate immune tolerance.
Sroka EM; Lavigne M; Pla M; Daskalogianni C; Tovar-Fernandez MC; Prado Martins R; Manoury B; Darrasse-Jéze G; Nascimento M; Apcher S; Fåhraeus R
Proc Natl Acad Sci U S A; 2023 Feb; 120(7):e2208509120. PubMed ID: 36745791
[TBL] [Abstract][Full Text] [Related]
12. Are ERAD components involved in cross-presentation?
Grotzke JE; Cresswell P
Mol Immunol; 2015 Dec; 68(2 Pt A):112-5. PubMed ID: 26005101
[TBL] [Abstract][Full Text] [Related]
13. Viral and bacterial minigene products are presented by MHC class I molecules with similar efficiencies.
Wolf BJ; Princiotta MF
Mol Immunol; 2011 Jan; 48(4):463-71. PubMed ID: 21067810
[TBL] [Abstract][Full Text] [Related]
14. Premature translational termination products are rapidly degraded substrates for MHC class I presentation.
Lacsina JR; Marks OA; Liu X; Reid DW; Jagannathan S; Nicchitta CV
PLoS One; 2012; 7(12):e51968. PubMed ID: 23251665
[TBL] [Abstract][Full Text] [Related]
15. IRAP identifies an endosomal compartment required for MHC class I cross-presentation.
Saveanu L; Carroll O; Weimershaus M; Guermonprez P; Firat E; Lindo V; Greer F; Davoust J; Kratzer R; Keller SR; Niedermann G; van Endert P
Science; 2009 Jul; 325(5937):213-7. PubMed ID: 19498108
[TBL] [Abstract][Full Text] [Related]
16. MHC-I presentation of peptides derived from intact protein products of the pioneer round of translation.
Weinstein-Marom H; Hendel L; Laron EA; Sharabi-Nov A; Margalit A; Gross G
FASEB J; 2019 Oct; 33(10):11458-11468. PubMed ID: 31343935
[TBL] [Abstract][Full Text] [Related]
17. [Synthesis of MHC class I antigenic peptides in the nucleus: a role for the nuclear translation at last?].
Duvallet E; Boulpicante M; Apcher S
Med Sci (Paris); 2014 Mar; 30(3):229-31. PubMed ID: 24685205
[No Abstract] [Full Text] [Related]
18. An in vitro-transcribed-mRNA polyepitope construct encoding 32 distinct HLA class I-restricted epitopes from CMV, EBV, and Influenza for use as a functional control in human immune monitoring studies.
Nielsen JS; Wick DA; Tran E; Nelson BH; Webb JR
J Immunol Methods; 2010 Aug; 360(1-2):149-56. PubMed ID: 20637775
[TBL] [Abstract][Full Text] [Related]
19. Tumors escape immunosurveillance by overexpressing the proteasome activator PSME3.
Boulpicante M; Darrigrand R; Pierson A; Salgues V; Rouillon M; Gaudineau B; Khaled M; Cattaneo A; Bachi A; Cascio P; Apcher S
Oncoimmunology; 2020 May; 9(1):1761205. PubMed ID: 32923122
[TBL] [Abstract][Full Text] [Related]
20. Heat shock proteins in antigen trafficking--implications on antigen presentation to T cells.
Udono H; Ichiyanagi T; Mizukami S; Imai T
Int J Hyperthermia; 2009 Dec; 25(8):617-25. PubMed ID: 19551545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
